Travel report: Visit of LAL and of J.P. Girardeau-Montant, Lyon in october 1987

por Geissler, K, Hùbner, K
Publicado 1987

Intense laser-induced electron emission from prepoled PLZT ceramics

por Geissler, K, Gundel, H, Riege, H, Handerek, J
Publicado 1989

CLIC test facility cost evaluation and spending profile

por Baconnier, Y, Geissler, K, Hübner, K, Madsen, J H B
Publicado 1988

CLIC test facility

por Baconnier, Y, Geissler, K, Húbner, K, Madsen, J H B
Publicado 1988

Some tests of a multigap projection chamber

por Breskin, A, Charpak, Georges, Darriulat, Pierre, Geissler, K, Holder, M, Tittel, K
Publicado 1972

Enhancement of laser-induced electron emission from ferroelectrics by surface charge refreshment

por Geissler, K, Meineke, A, Riege, H, Handerek, J, Granzer, H, Suchland, D
Publicado 1992

Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors

por Geissler, K, Jäger, E, Barna, A, Alendar, T, Ljubuncic, E, Sliwa, T, Valent, P
Publicado 2016

Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects.

por Geusau, A, Abraham, K, Geissler, K, Sator, M O, Stingl, G, Tschachler, E
Publicado 2001

Organic Anion Transporting Polypeptide 5A1 (OATP5A1) in Small Cell Lung Cancer (SCLC) Cells: Possible Involvement in Chemoresistance to Satraplatin

por Olszewski-Hamilton, U., Svoboda, M., Thalhammer, T., Buxhofer-Ausch, V., Geissler, K., Hamilton, G.
Publicado 2011

Survey measurements of wire chamber behaviour in time

por Baehler, P, Bénichou, J L, Colemagne, R, Gavillet, Ph, Geissler K K, Pothier, J
Publicado 1980

The CERN linear collider test facility

por Baconnier, Y, Bossart, R, Geissler, K K, Godot, J C, Hübner, K, Kugler, H, Madsen, J H B, Riche, A J, Ströde, J, Suberlucq, G
Publicado 1990

The CERN linear collider test facility (CTF)

por Baconnier, Y, Battisti, S, Bossart, R, Delahaye, J P, Geissler, K K, Godot, J C, Hübner, K, Madsen, J H B, Potier, J P, Riche, A J, Sladen, J, Suberlucq, G, Wilson, I, Wuensch, W
Publicado 1992

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL

por Zinzani, P. L., Özcan, M., Sapunarova, K., Jurczak, W., Hamed, A., Bouabdallah, K., Saydam, G., Geissler, K., Szomor, Á., Lazaroiu, M., Salar, A., Tempescul, A., Nalcaci, M., Gercheva, L., Egyed, M., Panayiotidis, P., Mongay Soler, L., Cao, A., Phelps, C., H Childs, B., J Matasar, M.
Publicado 2022

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT...

por DeZern, A., Marconi, G., Deeren, D., Diez Campelo, M., Lübbert, M., Krishnamurthy, P., Nagy, Z., Basak, G., Jonášová, A., Morozova, E., Geissler, K., Ofran, Y., Kelley, H., Volkert, A., Baker, K., Kang-Fortner, Q., Hodgson, G., Madigan, C., Roth, D. A., Kelly, M., Fenaux, P.
Publicado 2022